Case Presentation: A 53-year-old female with Stage IV diffuse large B cell lymphoma (DLBCL) with Myc and Bcl2 rearrangements. Chemotherapeutic regimens were initially successful at achieving remission, but her disease ultimately progressed. The patient elected to pursue CD19-directed Chimeric Antigen Receptor (CAR)-T therapy (axi-cel), and hospital admission was planned for the duration of therapy. The [...]